“…The extramembrane location of these proteins makes them good candidates for vaccine development. The proteins E, prM, NS1 and NS3 have been identified by VaxiJen as probable antigens [96], and several B-and T-cell epitopes have been predicted [96][97][98]. The nonstructural protein NS5 is the most conserved DENV protein making it a good vaccine target [99].…”